CAH:NYSECardinal Health, Inc. Analysis
Data as of 2026-09-09 - not real-time
$238.85
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
At $238.84, Cardinal Health, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Across the trailing 30 sessions it gained 2.7%. With RSI at 52.6 the momentum picture is neutral, alongside a bullish MACD signal. Watch $227.68 as support and $249.29 as the nearer resistance level.
On valuation the read is fair — earnings multiple of 33.0 versus a 29.8 sector average, above the peer group. Consensus targets land 13.4% above where the shares trade now. Revenue is growing at 5.8% on a 0.7% profit margin. The 0.86% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 24.2%, a beta of -0.06 and a maximum drawdown of 20.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.
On valuation the read is fair — earnings multiple of 33.0 versus a 29.8 sector average, above the peer group. Consensus targets land 13.4% above where the shares trade now. Revenue is growing at 5.8% on a 0.7% profit margin. The 0.86% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 24.2%, a beta of -0.06 and a maximum drawdown of 20.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.
Top Market Events
WASHINGTON dpa-AFX - Healthcare services company Cardinal Health, Inc.Healthcare distributor and services company Cardinal Health NYSE:CAH in Q2 CY2026, but sales rose 5.Cardinal Health stock is trading near recent highs as investors weigh solid quarterly earnings, upbe
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 216.08
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 33.0 versus sector average of 29.8
- Trading above the 200-day average of 216.08
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 33.0 versus sector average of 29.8
- Analyst targets imply +13.4% versus the current price
- Dividend yield of 0.86%
Key Metrics & Analysis
Financial Health
Revenue Growth5.80%
Profit Margin0.67%
P/E Ratio33.0
ROA3.72%
P/B Ratio-19.3
Op. Cash Flow$5.2B
Free Cash Flow$4.8B
Industry P/E29.8
Technical Analysis
TrendBullish
RSI52.6
Support$227.68
Resistance$249.29
MA 20$236.85
MA 50$234.33
MA 200$216.08
MACDBullish
VolumeDecreasing
Fear & Greed Index92.48
Valuation
Fair Value$308.67
Target Price$270.94
Upside/Downside13.44%
GradeFair
TypeGrowth
Dividend Yield0.86%
Risk Assessment
Beta-0.06
Volatility24.23%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.